Following the company's first-quarter earnings report, shares of Hims & Hers Health (HIMS 5.21%) opened the following day considerably lower, only to sprint higher once trading began. This action is just one example of why the stock is a bit of a divisive name among investors. This can also be seen in its high short interest, which sits above 25%.The stock is up around 108% year to date (as of this writing), while at the same time it's down about 27% from the highs it set earlier this year. Let's take a clo ...

LifeMD (LFMD) Q1 2025 Earnings Call May 06, 2025 04:30 PM ET Company Participants Justin Schreiber - Chairman & CEOMarc Benathen - CFODavid Larsen - Managing DirectorSteve Dechert - AVP Conference Call Participants Sarah James - AnalystSteven Valiquette - MD & Senior Equity Research Analyst - Covering Health Care Technology & DistributionYi Chen - Managing Director & Senior AnalystAnderson Schock - Research Analyst Operator Good afternoon. Thank you for joining us today to discuss LifeMD's results for the f ...

LifeMD (LFMD) Q1 2025 Earnings Call May 06, 2025 04:30 PM ET Speaker0 Good afternoon. Thank you for joining us today to discuss LifeMD's results for the first quarter ended 03/31/2025. Joining the call today are Justin Schreiber, Chairman and Chief Executive Officer and Mark Benethen, Chief Financial Officer. Following management's prepared remarks, we will open the call for a question and answer session. Before we begin, I would like to remind everyone that during this call, the company will make a number ...

Justin Schreiber, Chairman and CEO of LifeMD, said, "LifeMD had an outstanding first quarter that demonstrated the power of our platform, the need for our services and the accelerated growth trajectory of the business as we achieved our first-ever quarter of GAAP profitability well ahead of expectations. During the quarter we expanded across all service areas, and the performance of our weight management program underscored our success as it is now expected to exceed top- and bottom-line expectations for th ...

Hims & Hers Health, Inc. (HIMS) reported $586.01 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 110.7%. EPS of $0.20 for the same period compares to $0.05 a year ago.The reported revenue represents a surprise of +8.91% over the Zacks Consensus Estimate of $538.1 million. With the consensus EPS estimate being $0.12, the EPS surprise was +66.67%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compa ...

Hims & Hers Health (HIMS) Q1 2025 Earnings Call May 05, 2025 05:00 PM ET Company Participants Bill Newby - Senior Director, Investor RelationsAndrew Dudum - Co-Founder & Chief Executive OfficerYemi Okupe - Chief Financial OfficerJonna Kim - DirectorDavid Larsen - Managing Director Conference Call Participants Craig Hettenbach - AnalystMaria Ripps - Managing Director, Senior Research AnalystEric Percher - Research Analyst - Pharma Supply Chain and HCITRyan Macdonald - Senior AnalystDaniel Grosslight - Senior ...

Hims & Hers Health (HIMS) Q1 2025 Earnings Call May 05, 2025 05:00 PM ET Speaker0 Good afternoon, ladies and gentlemen. Thank you for standing by. At this time, I would like to welcome everyone to the Speaker1 Hims Hens and Hers Health first quarter twenty twenty five earnings call. Today, after the market closed, we released this quarter's shareholder letter, a copy of which you can find on our website at investors.hens.com. On the call with me today is Andrew Dudum, our Co Founder and Chief Executive Offi ...

Shares of Hims & Hers Health fell 5% in extended trading on Monday after the company reported first-quarter earnings that beat analysts' expectations but offered weaker-than-expected guidance.Here's how the company did:Earnings per share: 20 cents vs. 12 cents expected by LSEGRevenue: $586 million vs. $538 million expected by LSEGRevenue at the telehealth company increased 111% in the first quarter from $278.2 million during the same period last year, according to a release. Hims & Hers reported a net incom ...

Bringing nearly 20 years of global experience at Amazon, Nader Kabbani is joining the executive leadership team to help the company further innovate on the delivery of affordable, seamless personalized care in the U.S. and globally.Hims & Hers Health on Monday announced Nader Kabbani, a former Amazon executive who helped establish many of its health-care offerings, will join the telehealth company as its chief operations officer.Kabbani spent nearly 20 years at Amazon, where he oversaw the launch of Amazon ...

Hims & Hers (NYSE: HIMS ) is changing the way healthcare is administered in the 21st century, which is increasingly reflected by its surging topline. The company grew its 2024 revenue by 69% YoY to $1.5"AWS Certified AI Practitioner Early Adopter"I am a DevOps Engineer for a major, wholly owned subsidiary of a large-cap Fortune 500. I am a true subject-matter expert on the actual buildout, deployment, and maintenance of AI tools and applications. I have increasingly deep knowledge on the science behind gene ...